189 related articles for article (PubMed ID: 6135081)
1. Cystic fibrosis and pseudomonas infection.
Lancet; 1983 Jul; 2(8344):257-8. PubMed ID: 6135081
[No Abstract] [Full Text] [Related]
2. Study of IgG antibodies to Pseudomonas aeruginosa in early cystic fibrosis infection.
Giordano A; Magni A; Filadoro F; Graziani C; Quattrucci S; Cipriani P
New Microbiol; 1998 Oct; 21(4):375-8. PubMed ID: 9812319
[TBL] [Abstract][Full Text] [Related]
3. Serogroups of Pseudomonas aeruginosa and the immune response of patients with cystic fibrosis.
Diaz E; Mosovich LL; Neter E
J Infect Dis; 1970 Mar; 121(3):269-74. PubMed ID: 4984335
[No Abstract] [Full Text] [Related]
4. Microbiological background for anti-Pseudomonas aeruginosa vaccination in cystic fibrosis.
Bauernfeind A; Przyklenk B
Behring Inst Mitt; 1997 Feb; (98):256-61. PubMed ID: 9382748
[No Abstract] [Full Text] [Related]
5. An ELISA to detect antipseudomonal IgA antibodies in sera of patients with cystic fibrosis.
Brett MM; Ghoneim AT; Littlewood JM
J Clin Pathol; 1988 Oct; 41(10):1130-4. PubMed ID: 3142934
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of specific immune response in early P. aeruginosa infection in cystic fibrosis patients.
Dolce D; Cariani L; Campana S; Ravenni N; Mergni G; Biffi A; Colombo C; Gagliardini R; Cirilli N; Manso E; Padoan R; Soncini E; Forte FR; D'Aprile A; Ratclif L; Amboni M; Casciaro R; Minicucci L; Borio T; Cosimi A; Vieni G; Zinnarello C; Fiscarelli E; Collura M; Pensabene T; Braggion C; Döring G; Taccetti G
J Cyst Fibros; 2014 Jan; 13(1):116-7. PubMed ID: 24022018
[No Abstract] [Full Text] [Related]
7. [Anti-pseudomonas-specific precipitins as a marker of chronic infection in patients with cystic fibrosis].
Castello D; Mari C; Visca A
Minerva Pediatr; 1999 Mar; 51(3):47-51. PubMed ID: 10368566
[TBL] [Abstract][Full Text] [Related]
8. Influence of inflammatory response, infection, and pulmonary function in cystic fibrosis.
Pereira LC; Moreira EA; Bennemann GD; Moreno YM; Buss Zda S; Barbosa E; Ludwig-Neto N; Wilhelm Filho D; Fröde TS
Life Sci; 2014 Jul; 109(1):30-6. PubMed ID: 24931908
[TBL] [Abstract][Full Text] [Related]
9. Pseudomonas aeruginosa infection in cystic fibrosis. Occurrence of precipitating antibodies against pseudomonas aeruginosa in relation to the concentration of sixteen serum proteins and the clinical and radiographical status of the lungs.
Hoiby N; Jacobsen L; Jorgensen BA; Lykkegaard E; Weeke B
Acta Paediatr Scand; 1974 Nov; 63(6):843-8. PubMed ID: 4215280
[No Abstract] [Full Text] [Related]
10. Specific Pseudomonas immunoglobulin E antibodies in sera of patients with cystic fibrosis.
Shen J; Brackett R; Fischer T; Holder A; Kellogg F; Michael JG
Infect Immun; 1981 May; 32(2):967-8. PubMed ID: 6788704
[TBL] [Abstract][Full Text] [Related]
11. Pseudomonas aeruginosa infection in cystic fibrosis. Diagnostic and prognostic significance of pseudomonas aeruginosa precipitins determined by means of crossed immunoelectrophoresis. A survey.
Hoiby N
Acta Pathol Microbiol Scand Suppl; 1977; (262):1-96. PubMed ID: 411327
[No Abstract] [Full Text] [Related]
12. Pseudomonas aeruginosa infection in cystic fibrosis. Relative prevalence of antibodies in serum against cathodic and anodic migrating P. aeruginosa antigens determined by immunoelectrophoretic methods.
Holby N
Acta Pathol Microbiol Scand C; 1977 Apr; 85(2):149-52. PubMed ID: 67746
[TBL] [Abstract][Full Text] [Related]
13. The immunoevasive activities of Pseudomonas aeruginosa. Relevance for cystic fibrosis.
Buret A; Cripps AW
Am Rev Respir Dis; 1993 Sep; 148(3):793-805. PubMed ID: 8368651
[No Abstract] [Full Text] [Related]
14. Toll-like receptors in the host defense against Pseudomonas aeruginosa respiratory infection and cystic fibrosis.
McIsaac SM; Stadnyk AW; Lin TJ
J Leukoc Biol; 2012 Nov; 92(5):977-85. PubMed ID: 22892106
[TBL] [Abstract][Full Text] [Related]
15. Serum antibodies to Pseudomonas aeruginosa in cystic fibrosis.
Brett MM; Ghoneim AT; Littlewood JM
Arch Dis Child; 1986 Nov; 61(11):1114-20. PubMed ID: 3098186
[TBL] [Abstract][Full Text] [Related]
16. Lipopolysaccharide is present in immune complexes isolated from sputum in patients with cystic fibrosis and chronic Pseudomonas aeruginosa lung infection.
Kronborg G; Shand GH; Fomsgaard A; Høiby N
APMIS; 1992 Feb; 100(2):175-80. PubMed ID: 1554493
[TBL] [Abstract][Full Text] [Related]
17. Quantitative analysis of the IgG and IgG subclass immune responses to chromosomal Pseudomonas aeruginosa beta-lactamase in serum from patients with cystic fibrosis by western blotting and laser scanning densitometry.
Petersen TD; Ciofu O; Pressler T; Giwercman B; Pedersen SS; Høiby N
Thorax; 1996 Jul; 51(7):733-8. PubMed ID: 8882082
[TBL] [Abstract][Full Text] [Related]
18. Value of serology in predicting Pseudomonas aeruginosa infection in young children with cystic fibrosis.
Douglas TA; Brennan S; Berry L; Winfield K; Wainwright CE; Grimwood K; Stick SM; Sly PD;
Thorax; 2010 Nov; 65(11):985-90. PubMed ID: 20889526
[TBL] [Abstract][Full Text] [Related]
19. Pseudomonas-infected cystic fibrosis patient sputum inhibits the bactericidal activity of normal human serum.
Schiller NL; Millard RL
Pediatr Res; 1983 Sep; 17(9):747-52. PubMed ID: 6413945
[TBL] [Abstract][Full Text] [Related]
20. [Pseudomonas aeruginosa antibodies in patients with cystic fibrosis: clinical implications].
Marianelli L; Campana S; Taccetti G; Gabbrielli M; Dei R
Pediatr Med Chir; 1994; 16(6):551-4. PubMed ID: 7708538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
